GLOBAL BLOOD THERAPEUTICS Trademark

Trademark Overview

On Friday, January 8, 2016, a trademark application was filed for GLOBAL BLOOD THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the GLOBAL BLOOD THERAPEUTICS trademark a serial number of 86870052. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 22, 2024. This trademark is owned by Global Blood Therapeutics, Inc.. The GLOBAL BLOOD THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hematological disorders such as sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions; pharmaceutical preparations for the treatment of pulmonary disorders such as idiopathic pulmonary fibrosis and acute lung injury; and pharmaceutical preparations for the treatment of cancers and inflammatory disorders
global blood therapeutics

General Information

Serial Number86870052
Word MarkGLOBAL BLOOD THERAPEUTICS
Filing DateFriday, January 8, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 22, 2024
Registration Number5288014
Registration DateTuesday, September 12, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of hematological disorders such as sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions; pharmaceutical preparations for the treatment of pulmonary disorders such as idiopathic pulmonary fibrosis and acute lung injury; and pharmaceutical preparations for the treatment of cancers and inflammatory disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 22, 2024
Primary Code005
First Use Anywhere DateFriday, June 2, 2017
First Use In Commerce DateFriday, June 2, 2017

Trademark Owner History

Party NameGlobal Blood Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameGlobal Blood Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Friday, March 22, 2024CANCELLED SEC. 8 (6-YR)
Thursday, November 17, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 17, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 17, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 17, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 17, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, September 12, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, June 23, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, April 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 4, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, September 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 9, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 9, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 12, 2017REGISTERED-SUPPLEMENTAL REGISTER
Wednesday, August 9, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, July 28, 2017ASSIGNED TO LIE
Saturday, July 22, 2017NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Friday, July 21, 2017APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Friday, July 21, 2017USE AMENDMENT ACCEPTED
Thursday, June 8, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 8, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 8, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, June 7, 2017AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, June 7, 2017USE AMENDMENT FILED
Tuesday, June 6, 2017TEAS AMENDMENT OF USE RECEIVED
Saturday, December 10, 2016NOTIFICATION OF FINAL REFUSAL EMAILED
Saturday, December 10, 2016FINAL REFUSAL E-MAILED
Saturday, December 10, 2016FINAL REFUSAL WRITTEN
Tuesday, October 25, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 25, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 25, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 26, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 26, 2016NON-FINAL ACTION E-MAILED
Tuesday, April 26, 2016NON-FINAL ACTION WRITTEN
Friday, April 22, 2016ASSIGNED TO EXAMINER
Friday, January 15, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 12, 2016NEW APPLICATION ENTERED

Related Keywords

therapeutics blood global pharmaceutical treatment preparations disorders such pulmonary acute fibrosis cancers inflammatory